Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C.
Lin, Yong Q
Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C. [electronic resource] - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists - 135-9 p. digital
Publication Type: Case Reports; Clinical Conference; Journal Article
1530-891X
10.4158/EP.11.2.135 doi
Adrenergic beta-Antagonists--therapeutic use
Antithyroid Agents--therapeutic use
Antiviral Agents--adverse effects
Drug Therapy, Combination
Female
Hepatitis C, Chronic--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--adverse effects
Middle Aged
Patient Compliance
Polyethylene Glycols
Propranolol--therapeutic use
Propylthiouracil--therapeutic use
Recombinant Proteins
Retreatment
Ribavirin--adverse effects
Severity of Illness Index
Thyrotoxicosis--chemically induced
Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C. [electronic resource] - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists - 135-9 p. digital
Publication Type: Case Reports; Clinical Conference; Journal Article
1530-891X
10.4158/EP.11.2.135 doi
Adrenergic beta-Antagonists--therapeutic use
Antithyroid Agents--therapeutic use
Antiviral Agents--adverse effects
Drug Therapy, Combination
Female
Hepatitis C, Chronic--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--adverse effects
Middle Aged
Patient Compliance
Polyethylene Glycols
Propranolol--therapeutic use
Propylthiouracil--therapeutic use
Recombinant Proteins
Retreatment
Ribavirin--adverse effects
Severity of Illness Index
Thyrotoxicosis--chemically induced